Glaukos GKOS Stock
Glaukos Price Chart
Glaukos GKOS Financial and Trading Overview
| Glaukos stock price | 98.23 USD |
| Previous Close | 66.86 USD |
| Open | 66.94 USD |
| Bid | 0 USD x 900 |
| Ask | 70.62 USD x 1300 |
| Day's Range | 66.44 - 68.44 USD |
| 52 Week Range | 40.45 - 70.05 USD |
| Volume | 601.34K USD |
| Avg. Volume | 430.01K USD |
| Market Cap | 3.25B USD |
| Beta (5Y Monthly) | 1.227112 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.78 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 65.56 USD |
GKOS Valuation Measures
| Enterprise Value | 3.32B USD |
| Trailing P/E | N/A |
| Forward P/E | -36.48108 |
| PEG Ratio (5 yr expected) | -3.73 |
| Price/Sales (ttm) | 11.2550335 |
| Price/Book (mrq) | 6.3627787 |
| Enterprise Value/Revenue | 11.475 |
| Enterprise Value/EBITDA | -40.05 |
Trading Information
Glaukos Stock Price History
| Beta (5Y Monthly) | 1.227112 |
| 52-Week Change | 55.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 70.05 USD |
| 52 Week Low | 40.45 USD |
| 50-Day Moving Average | 55.51 USD |
| 200-Day Moving Average | 51.12 USD |
GKOS Share Statistics
| Avg. Volume (3 month) | 430.01K USD |
| Avg. Daily Volume (10-Days) | 742.48K USD |
| Shares Outstanding | 48.21M |
| Float | 46.36M |
| Short Ratio | 12.01 |
| % Held by Insiders | 3.85% |
| % Held by Institutions | 99.42% |
| Shares Short | 5.56M |
| Short % of Float | 16.66% |
| Short % of Shares Outstanding | 11.54% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -48.15% |
| Operating Margin (ttm) | -39.81% |
| Gross Margin | 75.79% |
| EBITDA Margin | -28.65% |
Management Effectiveness
| Return on Assets (ttm) | -7.10% |
| Return on Equity (ttm) | -25.16% |
Income Statement
| Revenue (ttm) | 289.08M USD |
| Revenue Per Share (ttm) | 6.07 USD |
| Quarterly Revenue Growth (yoy) | 9.19% |
| Gross Profit (ttm) | 213.88M USD |
| EBITDA | -82826000 USD |
| Net Income Avi to Common (ttm) | -139198000 USD |
| Diluted EPS (ttm) | -2.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 317.77M USD |
| Total Cash Per Share (mrq) | 6.6 USD |
| Total Debt (mrq) | 383.24M USD |
| Total Debt/Equity (mrq) | 75.37 USD |
| Current Ratio (mrq) | 6.666 |
| Book Value Per Share (mrq) | 10.607 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -73621000 USD |
| Levered Free Cash Flow (ttm) | -46998248 USD |
Profile of Glaukos
| Country | United States |
| State | CA |
| City | Aliso Viejo |
| Address | One Glaukos Way |
| ZIP | 92656 |
| Phone | 949 367 9600 |
| Website | https://www.glaukos.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 783 |
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, an implantable device intended to reduce the intraocular pressure of the eye; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo California.
Q&A For Glaukos Stock
What is a current GKOS stock price?
Glaukos GKOS stock price today per share is 98.23 USD.
How to purchase Glaukos stock?
You can buy GKOS shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Glaukos?
The stock symbol or ticker of Glaukos is GKOS.
Which industry does the Glaukos company belong to?
The Glaukos industry is Medical Devices.
How many shares does Glaukos have in circulation?
The max supply of Glaukos shares is 49.47M.
What is Glaukos Price to Earnings Ratio (PE Ratio)?
Glaukos PE Ratio is now.
What was Glaukos earnings per share over the trailing 12 months (TTM)?
Glaukos EPS is -2.78 USD over the trailing 12 months.
Which sector does the Glaukos company belong to?
The Glaukos sector is Healthcare.
Glaukos GKOS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE COMPOSITE (DJ) NYA | 17639.04 USD — |
-1.54
|
— — | — — | — — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2541.54 USD — |
-1.89
|
— — | 2531.95 USD — | 2572.66 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2060.1 USD — |
-1.99
|
— — | 2051.95 USD — | 2093.4 USD — | — - | — — |
- {{ link.label }} {{link}}